N
Nannette Y. Yount
Researcher at UCLA Medical Center
Publications - 29
Citations - 4519
Nannette Y. Yount is an academic researcher from UCLA Medical Center. The author has contributed to research in topics: Antimicrobial peptides & Antimicrobial. The author has an hindex of 17, co-authored 29 publications receiving 4071 citations. Previous affiliations of Nannette Y. Yount include Los Angeles Biomedical Research Institute & St. John's University.
Papers
More filters
Journal ArticleDOI
Mechanisms of Antimicrobial Peptide Action and Resistance
TL;DR: The intention of this review is to illustrate the contemporary structural and functional themes among mechanisms of antimicrobial peptide action and resistance.
Journal ArticleDOI
Multidimensional signatures in antimicrobial peptides
TL;DR: The multidimensional signature model provides a unifying structural theme in broad classes of antimicrobial peptides, will facilitate discovery of antimacterial peptides as yet unknown, and offers insights into the evolution of molecular determinants in these and related host defense effector molecules.
Journal ArticleDOI
Advances in antimicrobial peptide immunobiology
Nannette Y. Yount,Arnold S. Bayer,Arnold S. Bayer,Arnold S. Bayer,Yan Q. Xiong,Yan Q. Xiong,Yan Q. Xiong,Michael R. Yeaman,Michael R. Yeaman,Michael R. Yeaman +9 more
TL;DR: It appears that a relatively limited set of physicochemical features is required for antimicrobial peptide efficacy against a broad spectrum of microbial pathogens.
Journal ArticleDOI
Unifying themes in host defence effector polypeptides
TL;DR: Understanding how nature has sustained these host defence molecules with a potent efficacy in the face of dynamic microbial evolution should provide new opportunities to prevent or treat life-threatening infections.
Journal ArticleDOI
Emerging themes and therapeutic prospects for anti-infective peptides.
TL;DR: Emerging themes continue to highlight the potential of HDP-based anti-infectives as a platform for next-generation therapeutics that will help address the growing threat of multidrug-resistant infections.